Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07592520 · ClinicalTrials.gov registry record · Phase 4
Flush, Lyse, Operate
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT07592520 is a Phase 4 study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT07592520, a Phase 4 study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn if saline results in improvement for patients with infection of their plerual space. The main question it aims to answer is: What is the time to chest tube removal? Do these patients after need to escalate to fibrinolytics? Do these patients after need to escalate to surgery? Participants will: * Receive receive saline into their pleural space through an existing chest tube * If they fail to improve, which will be determined by fluid size after treatment or signs of persistent infection, they will receive fibrynolytics through an existing chest tube * If they fail to improve, which will be determined by fluid size after treatment or signs of persistent infection, they will be referred to surgery.
Interventions
- DRUG Intrapleural Saline with possible escalation to intraplerual alteplase and dornase.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07592520
The ClinicalTrials.gov registry entry for NCT07592520 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intrapleural Saline with possible escalation to intraplerual alteplase and dornase. is the first listed.
NCT07592520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07592520 about?
NCT07592520 is a clinical study titled "Flush, Lyse, Operate". The goal of this observational study is to learn if saline results in improvement for patients with infection of their plerual space. The main question it aims to answer is: What is the time to chest tube removal? Do these patients after need to escalate to fibrinolytics? Do these patients after ne...
What is the current status of trial NCT07592520?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2026-04. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07592520?
The interventions under investigation include: Intrapleural Saline with possible escalation to intraplerual alteplase and dornase. (DRUG).
Who is sponsoring clinical trial NCT07592520?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.